These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23580852)

  • 21. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH; Chen MS
    Am J Ophthalmol; 2008 Aug; 146(2):211-217. PubMed ID: 18547539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.
    Yeh PT; Yang CH; Yang CM
    Acta Ophthalmol; 2011 Nov; 89(7):634-40. PubMed ID: 20064118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal bevacizumab for proliferative diabetic retinopathy with new dense vitreous hemorrhage after full panretinal photocoagulation.
    Sinawat S; Rattanapakorn T; Sanguansak T; Yospaiboon Y; Sinawat S
    Eye (Lond); 2013 Dec; 27(12):1391-6. PubMed ID: 24037235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.
    Diabetic Retinopathy Clinical Research Network*
    JAMA Ophthalmol; 2013 Mar; 131(3):283-93. PubMed ID: 23370902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage.
    Cheema RA; Mushtaq J; Al-Khars W; Al-Askar E; Cheema MA
    Retina; 2010; 30(10):1646-50. PubMed ID: 20634777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical Trial.
    Arevalo JF; Lasave AF; Kozak I; Al Rashaed S; Al Kahtani E; Maia M; Farah ME; Cutolo C; Brito M; Osorio C; Navarro P; Wu L; Berrocal MH; Morales-Canton V; Serrano MA; Graue-Wiechers F; Sabrosa NA; Alezzandrini AA; Gallego-Pinazo R;
    Am J Ophthalmol; 2019 Nov; 207():279-287. PubMed ID: 31095954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ziv-aflibercept versus bevacizumab administration prior to diabetic vitrectomy: a randomised and controlled trial.
    Aleman I; Castillo Velazquez J; Rush SW; Rush RB
    Br J Ophthalmol; 2019 Dec; 103(12):1740-1746. PubMed ID: 30705040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of intravitreal bevacizumab in Eales disease with dense vitreous hemorrhage: a prospective randomized control study.
    Patwardhan SD; Azad R; Shah BM; Sharma Y
    Retina; 2011 May; 31(5):866-70. PubMed ID: 21301382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage.
    Farahvash MS; Majidi AR; Roohipoor R; Ghassemi F
    Retina; 2011; 31(7):1254-60. PubMed ID: 21499192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anterior retinal cryotherapy and intravitreal injection of bevacizumab in the treatment of nonclearing vitreous hemorrhage in proliferative diabetic retinopathy.
    Hsieh MC; Yeh PT; Yang CM; Yang CH
    J Ocul Pharmacol Ther; 2014 May; 30(4):353-8. PubMed ID: 24359129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin).
    Lo WR; Kim SJ; Aaberg TM; Bergstrom C; Srivastava SK; Yan J; Martin DF; Hubbard GB
    Retina; 2009; 29(7):926-31. PubMed ID: 19584650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intravitreal injection of bevacizumab on inflammatory cytokines in the vitreous with proliferative diabetic retinopathy.
    Suzuki Y; Suzuki K; Yokoi Y; Miyagawa Y; Metoki T; Nakazawa M
    Retina; 2014 Jan; 34(1):165-71. PubMed ID: 23851630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1.
    Sohn EH; He S; Kim LA; Salehi-Had H; Javaheri M; Spee C; Dustin L; Hinton DR; Eliott D
    Arch Ophthalmol; 2012 Sep; 130(9):1127-34. PubMed ID: 22965588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study.
    Jirawison C; Ittipunkul N
    J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S136-42. PubMed ID: 22696866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bevacizumab as an adjunct to vitreoretinal surgery for diabetic retinopathy in East Africa.
    Guthrie G; Hall AB; Dhalla K; Davies RM; Steel DH
    Eye (Lond); 2013 Nov; 27(11):1263-8. PubMed ID: 23949489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of before versus after intravitreal bevacizumab injection, growth factor levels and fibrotic markers in vitreous samples from patients with proliferative diabetic retinopathy.
    Ozer F; Tokuc EO; Albayrak MGB; Akpinar G; Kasap M; Karabas VL
    Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1899-1906. PubMed ID: 35028761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of bevacizumab for vitreous haemorrhage in proliferative diabetic retinopathy with prior complete panretinal photocoagulation.
    Park YJ; Ahn J; Kim TW; Park SJ; Joo K; Park KH; Shin JY
    Eye (Lond); 2021 Nov; 35(11):3056-3063. PubMed ID: 33420422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage?
    Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H
    Eur J Ophthalmol; 2009; 19(4):618-21. PubMed ID: 19551678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR).
    Rizzo S; Genovesi-Ebert F; Di Bartolo E; Vento A; Miniaci S; Williams G
    Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):837-42. PubMed ID: 18286296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. INTRAVITREAL BEVACIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Results From the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-up.
    Arevalo JF; Lasave AF; Wu L; Maia M; Diaz-Llopis M; Alezzandrini AA; Brito M;
    Retina; 2017 Feb; 37(2):334-343. PubMed ID: 27429384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.